Perivascular Adipose Tissue and Cardiometabolic Disease
Abstract
BACKGROUND: Obesity is associated with insulin resistance, hypertension, and cardiovascular disease, but the mechanisms underlying these associations are incompletely understood. Microvascular dysfunction may play an important role in the pathogenesis of both insulin resistance and hypertension in obesity.
CONTENT: Perivascular adipose tissue (PVAT) is a local deposit of adipose tissue surrounding the vasculature. PVAT is present throughout the body and has been shown to have a local effect on blood vessels. The influence of PVAT on the vasculature changes with increasing adiposity. PVAT similarly to other fat depots, is metabolically active, secreting a wide array of bioactive substances, termed ‘adipokines’. Adipokines include cytokines, chemokines and hormones that can act in a paracrine, autocrine or endocrine fashion. Many of the proinflammatory adipokines upregulated in obesity are known to influence vascular function, including endothelial function, oxidative stress, vascular stiffness and smooth muscle migration. Adipokines also stimulate immune cell migration into the vascular wall, potentially contributing to the inflammation found in atherosclerosis. Finally, adipokines modulate the effect of insulin on the vasculature, thereby decreasing insulin-mediated muscle glucose uptake. This leads to alterations in nitric oxide signaling, insulin resistance and potentially atherogenesis.
SUMMARY: PVAT surrounds blood vessels. PVAT and the adventitial layer of blood vessels are in direct contact with each other. Healthy PVAT secretes adipokines and regulates vascular function. Obesity is associated with changes in adipokine secretion and the resultant inflammation of PVAT. The dysregulation of adipokines changes the effect of PVAT on the vasculature. Changes in perivascular adipokines secretion in obesity appear to contribute to the development of obesity-mediated vascular disease.
KEYWORDS: obesity, perivascular adipose tissue, PVAT, cardiometabolic disease, adipokine
Full Text:
PDFReferences
Caterson ID, Hubbard V, Bray GA, Grunstein R, Hansen BC, Hong Y, et al. Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group III: worldwide comorbidities of obesity. Circulation. 2004; 110: E476-83, CrossRef.
Canoy D. Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol. 2008; 23: 591-8, CrossRef.
Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007; 116: 39-48, CrossRef.
Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J. 2009; 30: 850-6, CrossRef.
Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal adiposity and overall obesity in predicting risk of Type 2 diabetes among men. Am J Clin Nutr. 2005; 81: 555-63, PMID.
Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases. Int J Obes Relat Metab Disord. 2004; 28: S58-65, CrossRef.
Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008; 117: 605-13, CrossRef.
Lehman SJ, Massaro JM, Schlett CL, O’Donnell CJ, Hoffmann U, Fox CS. Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis. 2010; 210: 656-61, CrossRef.
Britton KA, Fox CS. Perivascular adipose tissue and vascular disease. Clin Lipidol. 2011; 6: 79-91, CrossRef.
Meijey RI, Serne EH, Smulders YM, van Hinsbergh VWM, Yudkin JS, Eringa EC. Perivascular adipose tissue and its role in type 2 diabetes and cardiovascular disease. Curr Diab Rep. 2011; 11: 211-7, CrossRef.
Campia U, Tesauro M, Cardillo C. Human obesity and endothelium-dependent responsiveness. Br J Pharmacol. 2011; 165: 561-73, CrossRef.
Ouchi N, Kihara S, Funahashi T, Matsuzawa Y, Walsh K. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol. 2003; 14: 561-6, CrossRef.
Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005; 96: 939-49, CrossRef.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011; 11: 85-97, CrossRef.
Samaras K, Botelho NK, Chisholm DJ, Lord RV. Subcutaneous and visceral adipose tissue gene expression of serum adipokines that predict type 2 diabetes. Obesity. 2010; 18: 884-9, CrossRef.
Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab. 1998; 83: 847-50, CrossRef.
Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res. 2009; 104: 541-9, CrossRef.
Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, et al. Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res. 2009; 105: 906-11, CrossRef.
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444: 860-7, CrossRef.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006; 116: 1793-801, CrossRef.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282: 2131-5, CrossRef.
Pradhan AD, Manson JE, Rifai N, Buring JE. Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001; 286: 327-34, CrossRef.
Lee DE, Kehlenbrink S, Lee H, Hawkins M, Yudkin JS. Getting the message across: mechanisms of physiological cross talk by adipose tissue. Am J Physiol Endocrinol Metab. 2009; 296: E1210-9, CrossRef.
Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010; 316: 129-39, CrossRef.
Ahima RS, Flier JS. Leptin. Annu Rev Physiol. 2000; 62: 413-7, CrossRef.
Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008; 52: 1201-10, CrossRef.
Sweeney G. Cardiovascular effects of leptin. Nat Rev Cardiol. 2010; 7: 22-9, CrossRef.
Hui X, Lam KSL, Vanhoutte PM, Xu A. Adiponectin and cardiovascular health: an update. Br J Pharmacol. 2012; 165: 574, CrossRef.
Chiarugi P, Fiaschi T. Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration. Expert Opin Ther Targets. 2010; 14: 193-206, CrossRef.
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002; 8: 1288-95, CrossRef.
Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol. 2002; 147: 173-80, CrossRef.
Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006; 55: 249-59, CrossRef.
Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86: 1930-5, CrossRef.
Lazar MA. Resistin- and Obesity-associated metabolic diseases. Horm Metab Res. 2007; 39: 710-6, CrossRef.
Fehmann HC, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res. 2006; 34: 671-3, CrossRef.
Jamaluddin MS, Weakly SM, Yao Q, Chen C. Resistin: functional roles and therapeutic considerations for vascular disease. Br J Pharmacol. 2012; 165: 622-32, CrossRef.
Wang Y. Small lipid-binding proteins in regulating endothelial and cascular functions: focusing on adipocyte fatty acid binging protein and lipocalin-2. Br J Pharmacol. 2012; 165: 603-21, CrossRef.
Bagi Z, Feher A, Cassuto J. Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol. 2012; 165: 544-60, CrossRef.
Barton M, Baretella O, Meyer MR. Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol. 2012, 165: 591-602, CrossRef.
Unger RH, Orci L. Diseases of liporegulation: new perspective on obesity and related disorders. FASEB J. 2001; 15: 312-21, CrossRef.
Schaffer JE. Lipotoxicity: when tissues overeat. Curr Opin Lipidol. 2003; 14: 281-7, CrossRef.
Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003; 108: 2460-6, CrossRef.
Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol. 2009; 29: 1458-64, CrossRef.
Verlohren S, Dubrovska G, Tsang SY, Essin K, Luft FC, Huang Y, et al. Visceral periadventitial adipose tissue regulates arterial tone of mesenteric arteries. Hypertension. 2004; 44: 271-6, CrossRef.
Yudkin JS, Eringa E, Stehouwer CD. “Vasocrine” signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet. 2005; 365: 1817-20, CrossRef.
Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation. 2009; 119: 1661-70, CrossRef.
Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, et al. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest. 2004; 113: 1258-65, CrossRef.
Thureson-Klein A, Stijarne L. Ultrastructural features of mast cells in human omental veins. Blood Vessels. 1979; 16: 311-9, CrossRef.
Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R, et al. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol. 2010; 30: 1576-82, CrossRef.
Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003; 88: 5163-8, CrossRef.
Rittig K, Staib K, Machann J, Bottcher M, Peter A, Schick F, et al. Perivascular fatty tissue at the brachial artery is linked to insulin resistance but not to local endothelial dysfunction. Diabetologia. 2008; 51: 2093-9, CrossRef.
Carroll JF, Dwyer TM, Grady AW, Reinhart GA, Montani JP, Cockrell K, et al. Hypertension, cardiac hypertrophy, and neurohumoral activity in a new animal model of obesity. Am J Physiol. 1996; 271: H373-8, PMID.
Soltis EE, Cassis LA. Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A. 1991; 13: 277-96, CrossRef.
Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM. Periadventitial fat releases a vascular relaxing factor. FASEB J. 2002; 16: 1057-63, CrossRef.
Dwyer TM, Mizelle HL, Cockrell K, Buhner P. Renal sinus lipomatosis and body composition in hypertensive, obese rabbits. Int J Obes Relat Metab Disord. 1995; 19: 869-74, PMID.
Danias PG, Tritos NA, Stuber M, Botnar RM, Kissinger KV, Manning WJ. Comparison of aortic elasticity determined by cardiovascular magnetic resonance imaging in obese vs lean adults. Am J Cardiol. 2003; 91: 195-9, CrossRef.
Wildman RP, Mackey RH, Bostom A, Thompson T, Sutton-Tyrrell K. Measures of obesity are associated with vascular stiffness in young and older adults. Hypertension. 2003; 42: 468-73, CrossRef.
Tounian P, Aggoun Y, Dubern B, Varille V, Guy-Grand B, Sidi D, et al. Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet. 2001; 358: 1400-4, CrossRef.
Hall JE, Brands MW, Dixon WN, Smith Jr MJ. Obesity-induced hypertension. Renal function and systemic hemodynamics. Hypertension. 1993; 22: 292-9, CrossRef.
Antic V, Kiener-Belforti F, Tempini A, Van Vliet BN, Montani JP. Role of the sympathetic nervous system during the development of obesity-induced hypertension in rabbits. Am J Hypertens. 2000; 13: 556-9, CrossRef.
Granger JP, West D, Scott J. Abnormal pressure natriuresis in thedog model of obesity-induced hypertension. Hypertension. 1994; 23: I8-11, CrossRef.
Montani JP, Antic V, Yang Z, Dulloo A. Pathways from obesity to hypertension: from the perspective of a vicious triangle. Int J Obes Relat Metab Disord. 2002; 26 (Suppl 2): S28-38, CrossRef.
Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 1997; 10: S49-55, CrossRef.
Vanhoutte PM. Obesity and vascular dysfunction: he fat-e of rich and poor. Br J Nutr. 2012, 165: 541-3, CrossRef.
Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980; 288: 373-6, CrossRef.
De Mey JG, Vanhoutte PM. Heterogeneous behavior of the canine arterial and venous wall. Importance of the endothelium. Circ Res. 1982; 51: 439-47, CrossRef.
Vanhoutte PM. The endothelium-modulator of vascular smooth-muscle tone. N Engl J Med. 1988; 319: 512-3, CrossRef.
Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989; 3: 2007-17, PMID.
Félétou M, Vanhoutte PM. EDHF: an update. Clin Sci. 2009; 117: 139-55, CrossRef.
Vanhoutte PM. How we learned to say NO. Arterioscler Thromb Vasc Biol. 2009; 29: 1156-60, CrossRef.
Vanhoutte PM. Endothelium-dependent contractions in hypertension: when prostacyclin becomes ugly. Hypertension. 2011; 57: 526-31, CrossRef.
Vanhoutte PM, Tang E, Félétou M, Shimokawa H. Endothelial dysfunction and vascular disease. Acta Physiol. 2009; 196: 193-222, CrossRef.
Garland CJ, Weston AH. The vascular endothelium: still amazing us 30 years on. Br J Pharmacol. 2011; 164: 837-8, CrossRef.
Rodriguez-Pascual F, Busnadiego O, Lagares D, Lamas S. Role of endothelin in the cardiovascular system. Pharmacol Res. 2011; 63: 463-72, CrossRef.
Rubanyi GM. The discovery of endothelin: the power of bioassay and the role of serendipity in the discovery of endothelium-derived vasoactive substances. Pharmacol Res. 2011; 63: 448-54, CrossRef.
Rajsheker S, Manka D, Blomkalns AL, Chatterjee TK, Stoll LL, Weintraub NL. Crosstalk between perivascular adipose tissue and blood vessels. Curr Opin Pharmacol. 2010; 10: 191-6, CrossRef.
Vela D, Buja LM, Madjid M, Burke A, Naghavi M, Willerson JT, et al. The role of periadventitial fat in atherosclerosis: an adipose subset with potential diagnostic and therapeutic implications. Arch Pathol Lab Med. 2007; 131: 481-7, PMID.
Chaldakov GN, Stankulov GN, Aloe L. Sub-epicardial adipose tissue in human coronary athero- sclerosis: another neglected phenomenon. Atherosclerosis. 2001; 154: 237-8, CrossRef.
Tellides G. Periadventitial fat: regional source of inflammation in atherosclerosis. Arch Pathol Lab Med. 2007; 131: 346-7, PMID.
Tore F, Tonches AB, Fiore M, uncel N, Atanassova P, Aloe L, et al. From adipose tissue protein secretion to adipopharmacology of disease. Immunol Endocr Metab Agents Med Chem. 2007; 7: 149-55, CrossRef.
Gao YL, Lu C, Su LY, Sharma AM, Lee RM. Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol. 2007; 151: 323-31, CrossRef.
Chaldakov GN, Tonchev AB, Fiore M, Aloe L, Stankulov IS. Periadventitial adipose tissue (tunica adipose): enemy or friend around. Arch Pathol Lab Med. 2007, 131: 1766, PMID.
Fortuno A, Rodriguez A, Gomez-Ambrosi J, Fruhbeck G, Diez J. Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem. 2003; 59: 51-60, CrossRef.
Thalmann S, Meier CA. Local adipose tissue depots as cardiovascular risk factors. Cardiovasc Res. 2007; 75: 690-701, CrossRef.
Yamawaki H, Tsubaki N, Mukohda M, Okada M, Hara Y. Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels. Biochem Biophys Res Commun. 2010; 393: 668-72, CrossRef.
Fesus G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC, et al. Adiponectin is a novel humoral vasodilator. Cardiovasc Res. 2007; 75: 719-27, CrossRef.
Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM, et al. Perivascular adipose tissue promotes vasoconstriction: The role of superoxide anion. Cardiovasc Res. 2006; 71: 363-73, CrossRef.
Gollasch M, Dubrovska G. Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol Sci. 2004; 25: 647-53, CrossRef.
Fortuno A, Rodriguez A, Gomez-Ambrosi J, Muniz P, Salvador J, Diez J, et al. Leptin inhibits angiotensin II-induced intracellular calcium increase and vasoconstriction in the rat aorta. Endocrinology. 2002; 143: 3555-60, CrossRef.
Engeli S. Is there a pathophysiological role for perivascular adipocytes? Am J Physiol Heart Circ Physiol. 2005; 289: H1794-5, CrossRef.
Schleifenbaum J, Kohn C, Voblova N, Dubrovska G, Zavarirskaya O, Gloe T et al. Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. J Hypertens. 2010; 28: 1875-82, CrossRef.
Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K et al. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008; 322: 587-90, CrossRef.
Feng X, Chen Y, Zhao J, Tang C, Jiang Z, Geng B. Hydrogen sulfide from adipose tissue is a novel insulin resistance regulator. Biochem Biophys Res Commun. 2009; 380: 153-9, CrossRef.
Fang L, Zhao J, Chen Y, Ma T, Xu G, Tang C, et al. Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J Hypertens. 2009; 27: 1034-49, CrossRef.
Gollasch M. Vasodilator signals from perivascular adipose tissue. Br J Pharmacol. 2012; 165: 633-42, CrossRef.
Ichiki T. Perivascular adipose tissue, a janus-faced regulator of vascular function. Circ J. 2010; 74: 1300-1, CrossRef.
Skilton MR, Serusclat A, Sethu AH, Brun S, Bernard S, Balkau B, et al. Noninvasive measurement of carotid extra-media thickness: Associations with cardiovascular risk factors and intima-media thickness. JACC Cardiovasc Imaging. 2009; 2: 176-82, CrossRef.
Aghamohammadzadeh R, Withers S, Lynch F, Greenstein A, Malik R, Heagerty A. Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a new pharmacotherapeutic target. Br J Pharmacol. 2012, 165: 670-82, CrossRef.
Lusis AJ. Atherosclerosis. Nature. 2000; 407: 233-41, CrossRef.
Ross R. The pathogenesis of atherosclerosis: a prospective for the 1990s. Nature. 1993; 362: 801-9, CrossRef.
Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med. 1999; 340: 115-26, CrossRef.
Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic andregulatory pathways. Physiol Rev. 2006; 86: 515-81, CrossRef.
Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol. 2008; 28: 812-9, CrossRef.
Maiellaro K, Taylor WR. The role of the adventitia in vascular inflammation. Cardiovasc Res. 2007; 75: 640-8, CrossRef.
Karastergiou K, Mohamed-Ali V. The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol. 2010; 318: 69-78, CrossRef.
Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, et al. Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol. 2005; 25: 2594-9, CrossRef.
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105: 1135-43, CrossRef.
Moreno PR, Purushothaman KR, Fuster V, O’Connor WN. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation. 2002; 105: 2504-11, CrossRef.
Pietrobelli A, Boner AL, Tato L. Adipose tissue and metabolic effects: new insight into measurements. Int J Obes Relat Metab Disord. 2005; 29: S97-100, CrossRef.
Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O’Donnell CJ, Hoffmann U. Comparison of anthropometric, area- and volumebased assessment of abdominal subcutaneous and visceral adipose tissue volumes using multidetector computed tomography. Int J Obes. 2007; 31: 500-6, CrossRef.
Fluchter S, Haghi D, Dinter D, Heberlein W, Kül HP, Neff W et al. Volumetric assessment of epicardial adipose tissue with cardiovascular magnetic resonance imaging. Obesity (Silver Spring). 2007; 15: 870-8, CrossRef.
Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O'Donnell CJ, Fox CS, et al. Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue. Int J Obes. 2009; 33: 226-32, CrossRef.
Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obesity. 2003; 11: 304-10, CrossRef.
Miao CY, Li ZY. The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Phamacol. 2012; 165: 643-58, CrossRef.
Liu J, Fox CS, Hickson DM, Sarpong D, Ekunwe L, May WD, et al. Pericardial adipose tissue, atherosclerosis, and cardiovascular disease risk factors. Diab Care. 2010; 33: 1635-9, CrossRef.
Boettcher M, Machann J, Stefan N, Thamer C, Haring HU, Claussen CD, et al. Intermuscular adipose tissue (IMAT): association with other adipose tissue compartments and insulin sensitivity. J Magn Reson Imaging. 2009; 29: 1340-5, CrossRef.
Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, et al. The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia. 2009; 52: 752-64, CrossRef.
Eringa EC, Bakker W, Smulders YM, Serne EH, Yudkin JS, Stehouwer CD. Regulation of vascular function and insulin sensitivity by adipose tissue: focus on perivascular adipose tissue. Microcirculation. 2007; 14: 389-402, CrossRef.
DOI: https://doi.org/10.18585/inabj.v5i1.46
Copyright (c) 2013 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
